Aequus Pharmaceuticals

Aequus Pharmaceuticals Inc. is a Vancouver-based specialty pharmaceutical company that develops and commercializes drugs primarily in Canada. The company focuses on therapeutic areas such as neurology, ophthalmology, and transplantation. Aequus markets several products, including Vistita, which helps reduce intraocular pressure in glaucoma patients, and Tacrolimus IR, an immunosuppressant used to prevent organ rejection. Additionally, it offers Evolve dry eye products that address symptoms like discomfort and dryness, as well as a preservative-free ophthalmic product. Aequus is also advancing several development-stage products, including extended-release oral tablets for epilepsy and a transdermal treatment for nausea during pregnancy. The company has established collaboration agreements with various partners for the promotion and distribution of its products. Founded in 2013, Aequus Pharmaceuticals aims to enhance drug delivery methods and improve patient compliance through innovative formulations.